Your browser doesn't support javascript.
loading
Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in Prostate Cancer.
Ruan, Hailong; Bao, Lin; Tao, Zhen; Chen, Ke.
Afiliación
  • Ruan H; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Bao L; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Tao Z; Department of Radiation Oncology and Cyberknife Center, Tianjin Medical University Cancer institute & Hospital, Tianjin, China. shenke@hust.edu.cn ztao@tmu.edu.cn.
  • Chen K; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. shenke@hust.edu.cn ztao@tmu.edu.cn.
Cancer Immunol Res ; 9(7): 838-852, 2021 07.
Article en En | MEDLINE | ID: mdl-34011528

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Neoplasias de la Próstata / Benzamidas / Transactivadores / Resistencia a Antineoplásicos / Antagonistas de Receptores Androgénicos / Proteínas de Microfilamentos / Nitrilos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Feniltiohidantoína / Neoplasias de la Próstata / Benzamidas / Transactivadores / Resistencia a Antineoplásicos / Antagonistas de Receptores Androgénicos / Proteínas de Microfilamentos / Nitrilos Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Immunol Res Año: 2021 Tipo del documento: Article